Health Care & Life Sciences » Pharmaceuticals | Hanmi Science Co. Ltd.

Hanmi Science Co. Ltd. | Mutual Funds

Mutual Funds that own Hanmi Science Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
185,406
0.28%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
115,545
0.18%
0
0.02%
09/05/2018
iShares MSCI South Korea Capped ETF
110,485
0.17%
0
0.22%
09/06/2018
104,973
0.17%
-141
0.36%
06/30/2017
iShares MSCI Emerging Markets ETF
76,891
0.12%
0
0.02%
09/06/2018
Mirae Asset TIGER 200
76,610
0.12%
1,995
0.21%
01/31/2018
Vanguard Developed Markets Index Fund
71,669
0.11%
0
0.01%
07/31/2018
Government Pension Fund - Global (The)
66,425
0.11%
62,757
0%
12/31/2017
Mirae Asset TIGER Health Care ETF
41,664
0.07%
10,262
2.18%
04/30/2018
Mirae Asset TIGER Consumer Staples ETF
30,664
0.05%
-19,638
1.27%
04/30/2018

About Hanmi Science Co.

View Profile
Address
214 Muha-ro
Hwaseong GY 18536
Korea, Republic Of
Employees -
Website http://www.hanmi.co.kr
Updated 07/08/2019
Hanmi Science Co., Ltd. is a holding company that engages in the management of its subsidiaries. It is mainly engaged in the manufacturing and selling of pharmaceutical ingredients and intermediates. The company was founded on June 15,1973 and is headquartered in Hwaseong, South Korea.